Canada· CA-DIN-02230769

DALMACOL

A opium-alkaloide und derivate, kombinationen product containing doxylamine succinate + sodium citrate + alcohol anhydrous + etafedrin hydrochloride, registered in Canada by LABORATOIRE RIVA INC.. The same ATC class is registered in 6 of our 19 countries.

ATC R05DA20

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedDALMACOLATCR05DA20REGISTER NO.CA-DIN-02230769PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Opium-alkaloide und derivate, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC R05DA20 (opium-alkaloide und derivate, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 4 of them publish a price we can compare per daily dose

Opium-alkaloide und derivate, kombinationen · ATC R05DA20

6 / 19 countries

  • Canada
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
DOXYLAMINE SUCCINATE + SODIUM CITRATE + ALCOHOL ANHYDROUS + ETAFEDRIN HYDROCHLORIDE
Manufacturer
LABORATOIRE RIVA INC.
Country
Canada (CA)
ATC code
R05DA20
ATC class
Opium-Alkaloide und Derivate, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2a0047f9-f12c-4809-b03f-6c8df826f453
GET /v1/drugs/2a0047f9-f12c-4809-b03f-6c8df826f453?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02230769",
  "form": "SYRUP",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R05DA20",
  "schedule": [
    "Narcotic (CDSA I)"
  ],
  "drug_code": "50030",
  "strengths": [
    "6 MG",
    "200 MG",
    "0.25 ML",
    "16.65 MG",
    "1.65 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "DOXYLAMINE SUCCINATE",
    "SODIUM CITRATE",
    "ALCOHOL ANHYDROUS",
    "ETAFEDRIN HYDROCHLORIDE",
    "HYDROCODONE BITARTRATE"
  ],
  "product_categorization": null
}

See everything about opium-alkaloide und derivate, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.